We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Deletions Affect Rapid Diagnostic Tests for Malaria

By LabMedica International staff writers
Posted on 25 Jul 2019
Prompt and accurate diagnosis of malaria is crucial for malaria case-management and control and elimination programmes. More...
While malaria diagnosis was historically based on symptoms alone, guidelines state that parasite-based diagnosis of malaria should be confirmed before treatment is given.

Malaria rapid diagnostic tests (mRDT) that target histidine-rich protein 2 (HRP2) are important tools for Plasmodium falciparum diagnosis. Parasites with pfhrp2/3 gene deletions threaten the use of these mRDTs, and have been reported in Africa, Asia, and South America. The absence of both HRP2 and HRP3 renders the parasites undetectable by HRP2-based mRDTs.

Scientists at the London School of Hygiene & Tropical Medicine (London, UK) and their colleagues analyzed P. falciparum parasites identified in human blood samples from three malaria studies in Ghana, Tanzania and Uganda. They analyzed 911 dried blood spots 165 from Ghana, 176 from Tanzania and 570 from Uganda (570). P. falciparum infection was confirmed by 18SrDNA polymerase-chain reaction (PCR), and pfhrp2/3 genes were genotyped.

True pfhrp2/3 gene deletions were confirmed if samples were (1) microscopy positive, (2) 18SrDNA polymerase chain (PCR) positive, (3) positive for merozoite surface protein genes by PCR, or positive by loop-mediated isothermal amplification (LAMP), and (4) quantitative PCR positive with > 5 parasites/µL. To confirm the deletion of pfhrp2 and pfhrp3 genes, PCR of two other single copy genes was performed.

The team reported that among the samples from Ghana, 107/165 (64.9%) were recorded as positive by mRDT and 82/165 (49.7%) by microscopy. In Tanzania, 72/171 (53.8%) samples were recorded as positive by mRDT, while 140/176 (79.6%) were positive by microscopy. Of the 570 Uganda samples, 258/570 (45.3%) were recorded as positive by mRDT, and 203 (35.6%) were positive by microscopy. No pfhrp2/3 deletions were detected in samples from Ghana, but deletions were identified in Tanzania (three pfhrp2; two pfhrp3) and Uganda (seven pfhrp2; two pfhrp3). Of the 10 samples with pfhrp2 deletions, nine tested negative by HRP2-based mRDT.

The authors concluded that the presence of pfhrp2/3 deletions in Tanzania and Uganda, along with reports of pfhrp2/3-deleted parasites in neighboring countries, reinforces the need for systematic surveillance to monitor the reliability of mRDTs in malaria-endemic countries. The study was published on June 28, 2019, in the Journal of Infectious Diseases.

Related Links:
London School of Hygiene & Tropical Medicine


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.